A sub-analysis of the 29,172 users who disclosed at least one side effect and mentioned a specific formulation found that 17,937 (61.5%) exclusively mentioned semaglutide formulations, and 7125 (24.4%) exclusively mentioned tirzepatide formulations
Konkalmatt PR, Asico LD, Zhang Y, Yang Y, Drachenberg C, Zheng X, Han F, Jose PA, Armando I
Building consistent habits around semaglutide duration and dosing schedules matters regardless of format
Results require 816 weeks of consistent daily use
1 Despite the FDA's assertions that the shortage for specific GLP-1 medications no longer applies, numerous compounding pharmacies have continued their production
Legal Disclaimer This product is for Topical and Cosmetic Use or Research Purposes Only